BETA: Please send your feedback!
Puma Biotechnology
PBYI:NAS
Biotechnology
—
MID cap
(—)
—
since start of 2021
—
- 1
- 3
- 1
- —
- 5
- 4
- 4
- 1
- —
- —
- —
- 3
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
About
Biotechnology
Founded 2010
Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.
website
Headquarters
Executives
Name | Title | Gender |
Richard Benton Phillips, PhD | Head-Regulatory Affairs & Quality Assurance | Male |
Alan H. Auerbach | Chairman, President, CEO & Secretary | Male |
Charles R. Eyler, MBA | Treasurer & Senior VP-Finance & Administration | Male |
Mariann Ohanesian | Senior Director-Investor Relations | Female |
Richard Paul Bryce, MD | Senior VP-Clinical Research & Development | Male |
Robert Charnas, PhD | Senior VP-Regulatory Affairs & Project Management | null |
Mindful Investing Summary
Puma Biotechnology - Competitors and Related Companies
How Puma Biotechnology stacks up to its peers in the Biotechnology industry or with competing business segments.
Puma Biotechnology
PBYI:NAS
Biotechnology
—
MID cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Array BioPharma
ARRY:NAS
Biotechnology
—
MID cap
(—)
—
since start of 2021
—
- 1
- 3
- 1
- —
- 5
- 4
- 4
- 1
- —
- —
- —
- 3
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
GlaxoSmithKline
GSK-GB:LON
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Pfizer
PFE:NYS
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership